Happy Head’s commitment to non-invasive hair regrowth solutions is part of what makes it stand out. The company believes in ...

The announcement of the pairing comes several months after Adare Pharma Solutions said it would upgrade several of its facilities, including in Milan, Italy, where the 3D printing operations will be ...

UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma ("cSCC ...

Tosti’s study, published in 2021, did find that low-dose oral minoxidil was an “effective and well-tolerated treatment ...

It is the first US approval for a topical gene therapy ... DEB is one of the more severe forms of the epidermolysis bullosa (EB) group – sometimes referred to as “the worst disease you ...

Kenalog (triamcinolone acetonide) is prescribed for certain inflammatory conditions. The dosage for Kenalog may vary depending on the condition being treated. Kenalog (triamcinolone acetonide ...

A severe form of this allergy is the Systemic nickel allergy syndrome, clinically characterized by cutaneous manifestions (contact dermatitis, pompholyx, hand dermatitis dyshydrosis, urticaria ...

UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...

Medicus Pharma Ltd. (Nasdaq: MDCX, TSXV: MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets.

A new approach to treat rosacea and other inflammatory skin conditions by inhibiting mast cells could be on the horizon.

The most forthright recommendations to avoid an error like the most recent event are to always label syringes and containers, and discard unlabeled products. However ...

Futura Medical's development of a topical treatment for erectile dysfunction (ED) is approaching the finish line in the US, as the UK biotech reports confirmatory phase 3 data ahead of an FDA ...